C1 esterase inhibitor concentrate in 1085 Hereditary Angioedema attacks - Final results of the I.M.P.A.C.T.2 study

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 66, Issue 12, 2011, Pages 1604-1611

  Craig, T J ^a   Bewtra, A K ^b   Bahna, S L ^c   Hurewitz, D ^d   Schneider, L C ^e   Levy, R J ^f   Moy, J N ^g   Offenberger, J ^h   Jacobson, K W ⁱ   Yang, W H ^j   Eidelman, F ^k   Janss, G ^l   Packer, F R ^m   Rojavin, M A ⁿ   Machnig, T ^o   Keinecke, H O ^p   Wasserman, R L ^q  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LOUISIANA STATE UNIVERSITY   (United States)

^d Allergy Clinic of Tulsa Inc   (United States)

^e BOSTON CHILDREN S HOSPITAL   (United States)

^f Family Allergy and Asthma Center   (United States)

^g University Consultants in Allergy and Immunology   (United States)

^h Allergy and Asthma Relief Experts   (United States)

ⁱ Allergy and Asthma Research Center   (United States)

^j Allergy and Asthma Research Center   (Canada)

^k DEPARTMENT OF COLORECTAL SURGERY   (United States)

^l Allergy Clinic   (United States)

^m Family First Medical Center   (United States)

ⁿ CSL Behring LLC   (United States)

^o CSL BEHRING GMBH   (Germany)

^p ACCOVION GMBH   (Germany)

^q DallasAllergyImmunology   (United States)

more..

Author keywords

Berinert; C1 esterase inhibitor concentrate; C1 inhibitor replacement therapy; Hereditary Angioedema

Indexed keywords

COMPLEMENT COMPONENT C1Q ANTIBODY; COMPLEMENT COMPONENT C1S INHIBITOR;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ADOLESCENT; ADULT; ANGIONEUROTIC EDEMA; ARTICLE; CHILD; CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFICACY; DRUG ERUPTION; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; FLU LIKE SYNDROME; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PERIANAL MYCOSIS; PRIORITY JOURNAL; RHINOPHARYNGITIS; SCHOOL CHILD; SINGLE DRUG DOSE; SYMPTOM; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION; VITAL SIGN; VULVOVAGINAL DISEASE;

ADOLESCENT; ADULT; ANGIOEDEMAS, HEREDITARY; ANTIBODIES; CHILD; COMPLEMENT C1 INHIBITOR PROTEIN; FEMALE; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 82955243866     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2011.02702.x     Document Type: Article

References (26)

1. Cugno M, Zanichelli A, Foieni F, Caccia S, Cicardi M. C1-inhibitor deficiency and angioedema: molecular mechanisms and clinical progress. Trends Mol Med 2009;15:69-78.
2. Cicardi M, Agostoni A. Hereditary angioedema. N Engl J Med 1996;334:1666-1667. (Pubitemid 26192529)
3. Zuraw BL. Clinical practice. Hereditary angioedema. N Engl J Med 2008;359:1027-1036.
4. Bowen T, Cicardi M, Farkas H, Bork K, Longhurst HJ, Zuraw B et al. A 2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema. Allergy Asthma Clin Immunol 2010;6:24.
5. Bork K. Pasteurized C1 inhibitor concentrate in hereditary angioedema: pharmacology, safety, efficacy and future directions. Expert Rev Clin Immunol 2008;4:13-20. (Pubitemid 351902492)
6. Cicardi M, Zingale LC, Zanichelli A, Deliliers DL, Caccia S. The use of plasmaderived C1 inhibitor in the treatment of hereditary angioedema. Expert Opin Pharmacother 2007;8:3173-3181.
7. Farkas H, Jakab L, Temesszentandrasi G, Visy B, Harmat G, Fust G et al. Hereditary angioedema: a decade of human C1-inhibitor concentrate therapy. J Allergy Clin Immunol 2007;120:941-947. (Pubitemid 47531846)
8. Waytes AT, Rosen FS, Frank MM. Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate. N Engl J Med 1996;334:1630-1634. (Pubitemid 26192522)
9. Craig TJ, Levy RJ, Wasserman RL, Bewtra AK, Hurewitz D, Obtuowicz K et al. Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks. J Allergy Clin Immunol 2009;124:801-808.
10. Zuraw BL, Busse PJ, White M, Jacobs J, Lumry W, Baker J et al. Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema. N Engl J Med 2010;363:513-522.
11. Zuraw B, Cicardi M, Levy RJ, Nuijens JH, Relan A, Visscher S et al. Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema. J Allergy Clin Immunol 2010;126:821-827.
12. Wasserman RL, Levy RJ, Bewtra AK, Hurewitz D, Craig TJ, Kiessling PC et al. Prospective study of C1 esterase inhibitor in the treatment of successive, acute abdominal and facial hereditary angioedema attacks. Ann Allergy Asthma Immunol 2011;106:62-68.
13. Craig TJ, Wasserman RL, Levy RJ, Bewtra AK, Schneider L, Packer F et al. Prospective study of rapid relief provided by C1 esterase inhibitor in emergency treatment of acute laryngeal attacks in hereditary angioedema. J Clin Immunol 2010;30:823-829.
14. Varga L, Fust G, Csuka D, Farkas H. Treatment with C1-inhibitor concentrate does not induce IgM type anti-C1 inhibitor antibodies in patients with hereditary angioedema. Mol Immunol 2010;48:572-576.
15. Verbruggen B, van Heerde WL, Laros-van Gorkom BA. Improvements in factor VIII inhibitor detection: from Bethesda to Nijmegen. Semin Thromb Hemost 2009;35:752-759.
16. Banerji A. Current treatment of hereditary angioedema: an update on clinical studies. Allergy Asthma Proc 2010;31:398-406.
17. Bernstein JA, Ritchie B, Levy RJ, Wasserman RL, Bewtra AK, Hurewitz DS et al. Hereditary angioedema: validation of the end point time to onset of relief by correlation with symptom intensity. Allergy Asthma Proc 2011;32:36-42.
18. Bork K, Staubach P, Hardt J. Treatment of skin swellings with C1-inhibitor concentrate in patients with hereditary angio-oedema. Allergy 2008;63:751-757. (Pubitemid 351591842)
19. Cicardi M, Bisiani G, Cugno M, Spath P, Agostoni A. Autoimmune C1 inhibitor deficiency: report of eight patients. Am J Med 1993;95:169-175. (Pubitemid 23242710)
20. Varga L, Fust G, Visy B, Harmat G, Karadi I, Farkas H. C1 inhibitor autoantibodies in hereditary angioedema (HAE). Mol Immunol 2003;40:223.
21. Varga L, Szeplaki G, Visy B, Fust G, Harmat G, Miklos K et al. C1-inhibitor (C1-INH) autoantibodies in hereditary angioedema. Strong correlation with the severity of disease in C1-INH concentrate naive patients. Mol Immunol 2007;44:1454-1460. (Pubitemid 44415947)
22. Bork K, Fremann S, Kreuz W. Long-term safety of C1 inhibitor concentrate in the treatment of acute hereditary angioedema attacks. Allergy 2010;65(Suppl. 92):78-208.
23. Ruconest CHMP assessment report [cited 1 June 2001]. Available from: http://www.ema.europa.eu/docs/en-GB/document-library/EPAR-Summary-for-the- public/human/001223/WC500098544.pdf.
24. Cicardi M, Levy RJ, McNeil DL, Li HH, Sheffer AL, Campion M et al. Ecallantide for the treatment of acute attacks in hereditary angioedema. N Engl J Med 2010;363:523-531.
25. Firazyr summary of product characteristics [cited 1 June 2011]. Available from: http://www.ema.europa.eu/docs/en-GB/document-library/EPAR-Product- Information/human/000899/WC500022966.pdf.
26. Cicardi M, Banerji A, Bracho F, Malbran A, Rosenkranz B, Riedl M et al. Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema. N Engl J Med 2010;363:532-541.